Vioxx Personal Injury Lawsuits


Personal injury attorneys representing clients who have allegedly been harmed by the prescription drug Vioxx are congratulating themselves over a historic judgment rendered recently. On August 19, 2005, a judge awarded the family of Bob Ernst $253.4 million due to his death from the drug. Vioxx, which had been prescribed most often for arthritis pain, was withdrawn globally by its maker, Merck, after research trials showed it increased patients' chances of a heart attack. Although Merck pulled the drug off the market in September 2004, legal action against this leading pharmaceutical giant will continue and expand. Let's take a look at why Vioxx has become a litigation lightning rod.

In 1998 as Merck was running clinical trials for Vioxx, company reports to the FDA stated that there were no cardiovascular signals apparent. This meant that there were no telltale signs that the drug could cause heart problems for users. Later, however, it was revealed that an internal study conducted by Merck around the same time - Study 090 - revealed serious cardiovascular problems as compared to patients not taking Vioxx. The study was never published by Merck as the company insisted that it was not large enough to provide definitive data.

The following year the FDA gave Vioxx its approval and the drug became the second nonsteroidal anti-inflammatory medication [or COX-2 inhibitor] to hit the market. Celebrex, another problem drug, was the first.

Merck widely and thoroughly launched a marketing campaign upon the introduction of Vioxx to the marketplace. Indeed, by 2003 the drug had entered 80 nations with sales exceeding $2.5 billion. Still, there were problems looming as ongoing tests conducted by Merck hinted of potential deadly side effects.

As early as 2001, the FDA recommended label warnings be put on prescriptions warning users of potential side effects. In addition, Merck was warned by the FDA to quit misleading physicians about potential side effects.

As potential problems began to surface, they served as red flags to industry watchdogs, to the FDA, as well as to personal injury attorneys who began to gather evidence to show that Merck was negligent. Indeed, web sites and advertising campaigns - meant to inform and attract patients harmed by the drug - were launched and fairly soon the internet, radio, television, and print media were flooded with advertisements asking those suspecting harm from Vioxx to come forward.

With the September 2004 announcement that Merck was withdrawing Vioxx, personal injury litigation was well on its way to being established. By early 2005, the first cases were filed and the Ernst case became the first Vioxx lawsuit to be settled.

Wrongful death lawsuits against Vioxx's maker, Merck, are expected to increase as the result of the Ernst decision. Personal injury attorneys insist that thousands of former Vioxx users and/or their families are due compensation for Merck's neglect. It remains to be seen if juries will render judgments as large as the Ernst judgment and whether courts will uphold these amounts. Nevertheless, it is certain that Merck is in for a long battle that will reach well beyond its US base.

Matthew Keegan is The Article Writer who writes on just about any and every issue imaginable. You can preview samples from his high performing site at http://www.thearticlewriter.com


MORE RESOURCES:

guardian.co.uk

Auto bailout: The best medicine?
Florida Times-Union, FL - 3 hours ago
By The Times-Union They already received $25 billion in low interest government loans intended to help them transition to a new generation of fuel efficient ...
Video: Automakers Testify As Hopes for Aid Falter AssociatedPress
The wrong medicine TheDay
Detroit bailout? No way! The Oregonian - OregonLive.com
Visalia Times-Delta - Vineland Daily Journal
all 1,492 news articles


University of South Alabama College of Medicine Chooses MDaudit(TM)
MarketWatch - 14 hours ago
... WIRE) -- Hayes Management Consulting announced today that it will provide its MDaudit(TM) software to University of South Alabama College of Medicine. ...


MinuteClinic co-founder launches e-medicine startup
Bizjournals.com, NC - 7 hours ago
Nearly a decade after he came up with the idea that became MinuteClinic, Rick Krieger thinks he’s come across a new way to change health care. ...


eFluxMedia

Three Employees Fired After Patient Chokes on Medicine, Dies
FOXNews - Nov 20, 2008
GOLDSBORO, NC — North Carolina officials have fired three employees and disciplined others in the death of a patient who was neglected for more than 22 ...
Firings a good first step in neglect case CharlotteObserver.com
all 39 news articles


Detroit prepares to swallow some bitter medicine
Financial Times, UK - 6 hours ago
By Bernard Simon in Los Angeles Among the many conditions imposed on Chrysler by Washington in the bail-out of 1979, none is said to have angered the ...


National Academy of Sports Medicine Launches New Course ...
MarketWatch - 19 hours ago
CALABASAS, CA, Nov 21, 2008 (MARKET WIRE via COMTEX) -- The National Academy of Sports Medicine (NASM; www.nasm.org), a leader in fitness training ...


Entry Level Finding Ways to Help Children With Cancer
New York Times, United States - 16 hours ago
She comes to the job with a master’s degree in Oriental medicine from Touro College and a lifelong love of cooking. On doing acupuncture on small children: ...


PR Web (press release)

BodyLogicMD Sponsors American Academy of Anti-Aging Medicine
MarketWatch - Nov 20, 2008
"It is a natural step for BodyLogicMD in terms of demonstrating our growth and support in the field of anti-aging medicine and bioidentical hormone therapy. ...
BodyLogicMD Opens Bioidentical Hormone Therapy Location in Chicago PR Web (press release)
all 12 news articles


Tongjitang Chinese Medicines Company to Announce Third Quarter ...
FOXBusiness - 15 hours ago
Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, ...


Research and Markets: This Global Research Report in Medicine and ...
MarketWatch - Nov 19, 2008
Nanomaterials, nanophotonics, nanoelectronics and nanoscience in medicine & biology represent the largest concentration of R&D. ...

Medicine - Google News

home | site map
© 2006